Pharmaceutical & Biotech

The pharmaceutical and biotech industry continues to flourish in the changing landscape of healthcare. Whether you focus on the discovery, development, or manufacturing of drugs and medications- we can connect you with leaders in your field to define best practices.

Pharmaceutical Conferences


Mitigating the risk of compliance enforcement action through the development and delivery of highly effective compliance training that engages employees on a global level, ensuring alignment with corporate standards and regulatory requirements.
JUNE 6-7, 2018 | CHICAGO, IL


Elevating Patient Advocacy through Creative, Patient-Centric Approaches to Engage with Advocacy Groups and Patients Directly, Ensuring Integration of the Patient Voice, Deep Levels of Comprehensive Support and Highest Levels of Value and Return on Investment
JULY 17-18, 2018 | BALTIMORE, MD


Enhancing product portfolio management operations through the employment of comprehensive data mining and analytical operations, engaging in thorough risk management assessments and defining the value of current pipeline products


Enhancing Medical Information Operations through Comprehensive Data Mining and Analytical Analysis Strategies to Improve Information Outreach, Harmonization of Messaging across Global Landscape and Patient Advocacy Perspective to Increase Impact of Medical Information Content
JULY 23-24, 2018 | BOSTON, MA

Latest News from our Pharmaceutical Blog

Find What Works For You

Technology is always changing. From new cell phones that help you connect to rockets that go out in to the universe. Technology empowers people to be innovative and create the best results. Stability testing is no different

Data Integrity While Building Stability Testing Program

Many industries require discretion and integrity. Stability testing is no different. One of the hottest topics in the stability industry is data integrity. Although this is not a new concept, new guidances have been put in place from the FDA. Data integrity is the...

Understanding and Incorporating ICH E6(R2)

In November 2016, ICH published an addendum to its guidelines for clinical practice, prompting pharmaceutical companies to align current clinical quality procedures with a risk-based monitoring approach.

PBMs Hold the Key to Pharmaceutical Success

Recent debates surrounding drug pricing have forced the pharmaceutical industry to navigate multiple avenues ensuring optimal coverage while maintaining high levels of ROI. Though the industry has worked extensively with insurance providers, building positive...

Will 2018 be Pharma’s Greatest Year Yet?

Will 2018 be Pharma’s Greatest Year Yet?   The pharmaceutical industry has faced many changes in 2017. Legislative uncertainty, patient-centricity, and ransomware threats are just a few of the industry’s hurdles so far. Looking ahead, however, the industry may be...

Forecasting Legislation and Industry Changes in the Trump Administration

Forecasting Legislation and Industry Changes in the Trump Administration   With the recent passing of the American Health Care Act (AHCA) through the U.S. House of Representatives, many industry leaders are anticipating the possible changes the AHCA may bring....

Patient Centricity is Changing the Pharmaceutical Industry

How the Patient Centricity is Changing the Pharmaceutical Industry   Over the past few years, drug makers have partnered with patients to deliver better drugs, gain more feedback, and provide more information about their products. This renewed focus on patient...

What Pharma Can Learn from WannaCry

What Pharma Can Learn from WannaCry   Over the past two weeks, healthcare networks across the globe have been infiltrated and patient data has been locked. These attacks, which are all connected to WannaCry ransomware, have spurred a conversation about what ransomware...

Trends Impacting Market Access and Coverage

Trends Impacting Market Access & Coverage The key to a successful product launch and quality patient care is market access and coverage. Obtaining high forumlary coverage is crucial to ensuring patients' access to treatments and increases the likelihood of...

Navigating Software Updates in the Electronic Submission Process with Pfizer

In recent years, advancements in technology have enabled regulatory operations and affairs teams to develop electronic submissions, streamlining the application process.

Q1 Productions
500 N. Dearborn Suite 500 | Chicago, IL 60654
Chicago, IL 60654
T: 312.822.8100
F: 312.873.3969

Share This